Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors
申请人:Chang Han-Ting
公开号:US20070135383A1
公开(公告)日:2007-06-14
The present invention provides methods and compositions for the treatment of phospholipase-related conditions. In particular, the invention provides a method of treating insulin-related, weight-related conditions and/or cholesterol-related conditions in an animal subject. The method generally involves the administration of a non-absorbed and/or effluxed phospholipase A2 inhibitor that is localized in a gastrointestinal lumen.
MULTIVALENT INDOLE COMPOUNDS AND USE THEREOF AS PHOSPHOLIPASE-A2 INHIBITORS
申请人:Ilypsa, Inc.
公开号:EP1960356A2
公开(公告)日:2008-08-27
US7666898B2
申请人:——
公开号:US7666898B2
公开(公告)日:2010-02-23
[EN] MULTIVALENT INDOLE COMPOUNDS AND USE THEREOF AS PHOSPHOLIPASE-A2 INHIBITORS<br/>[FR] COMPOSES D'INDOLE MULTIVALENTS ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE PHOSPHOLIPASES A2
申请人:ILYPSA INC
公开号:WO2007056281A2
公开(公告)日:2007-05-18
[EN] Indole and indole-related compounds, compositions and methods are disclosed. The compounds of the invention are useful as phospholipase inhibitors. The compounds and compositions of the invention are useful for treatment of phospholipase- related conditions, such as insulin-related, weight-related and/or cholesterol-related conditions in an animal subject. [FR] L'invention concerne de l'indole et des composés apparentés à l'indole, des compositions et des méthodes. Les composés de l'invention sont utiles en tant qu'inhibiteurs de phospholipases. Les composés et compositions de l'invention sont utiles pour le traitement d'états liés aux phospholipases, tels que les états liés à l'insuline, liés au poids et/ou liés au cholestérol chez un sujet animal.